Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Evaluating Non-Statistically Significant Results From Trials in Practice-Reply

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump for Cardiogenic Shock

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Association Between Neurological Disorders and Death by Suicide in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Clinical Question: Is treatment with methylphenidate associated with benefits or harms for children and adolescents with attention-deficit/hyperactivity disorder (ADHD)?

Bottom Line: Methylphenidate is associated with improvement in ADHD symptoms, general behavior, and quality of life; however, due to the very low quality of the evidence, the magnitude of the associated improvement is uncertain. Methylphenidate was associated with an increased risk of nonserious adverse events. There are too few data to assess the association with serious adverse events.

OriginalsprogEngelsk
TidsskriftJ A M A: The Journal of the American Medical Association
Vol/bind315
Udgave nummer18
Sider (fra-til)2009-2010
Antal sider2
ISSN0098-7484
DOI
StatusUdgivet - 10 maj 2016

ID: 46432737